Skip to main content

Author: Dagny Stuart

Design competition aims to assist laryngectomy patients

Mar. 29, 2018—The first annual LaryHacks, a competition to design innovative devices, apps or methods to assist laryngectomy patients who have had their voice boxes removed, has been set for Thursday, April 12, 5 to 8 p.m., in the Wond’ry, 2414 Highland Ave. in the Vanderbilt University Engineering and Science building.

Read more


Cancer immunotherapy drugs linked with more serious heart effects

Mar. 12, 2018—Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.

Read more


VICC study sheds new light on Von Hippel-Lindau syndrome

Mar. 8, 2018—Investigators at Vanderbilt-Ingram Cancer Center (VICC) and the Virginia Tech Carilion Research Institute (VTCRI) have revealed a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs.

Read more


Lovly earns scholarship grant for lung cancer research

Mar. 8, 2018—Christine Lovly, MD, PhD, assistant professor of Medicine at Vanderbilt, has received a $200,000 grant to support promising new research on lung cancer.

Read more


Team finds stem cell transplant improves scleroderma survival

Feb. 15, 2018—A new clinical trial by investigators at Vanderbilt University Medical Center (VUMC) and other leading medical centers found that an intensive transplant treatment using the patient’s own stem cells can improve survival and quality of life for patients with advanced scleroderma.

Read more


Study seeks to boost breast tumor immune response

Feb. 8, 2018—Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.

Read more


Sberna named VICC Strategy and Analytics director

Feb. 1, 2018—Theresa Sberna, MPH, has been named director of Strategy and Analytics for Vanderbilt-Ingram Cancer Center (VICC). Sberna, who previously served as associate director, has been with the Cancer Center for five years.

Read more


Rising obesity rates in South leading to rapid increase in diabetes

Jan. 18, 2018—Rising obesity rates in several Southern states are leading to a rapid increase in new cases of diabetes among both black and white adults. A new study helmed by investigators at the University of Texas Health Science Center and Vanderbilt University Medical Center (VUMC) found the risk of diabetes is double for black patients.

Read more


Study finds higher death rates in poor neighborhoods

Jan. 18, 2018—Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.

Read more


Macara named ‘Pink Tie Guy’ for Komen breast cancer research

Jan. 11, 2018—Ian Macara, PhD, Louise B. McGavock Professor and Chair of Cell and Developmental Biology and co-leader of the Signal Transduction and Chemical Biology Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the Pink Tie Guys for the Susan G. Komen Central Tennessee organization.

Read more


Lung screening program continues to grow

Jan. 11, 2018—Vanderbilt University Medical Center’s (VUMC) Lung Screening Program for patients at high risk for cancer recently reached a milestone, enrolling more than 700 patients and performing more than 1,000 CT screening examinations.

Read more


Rathmell elected to ASCO nominating committee

Dec. 19, 2017—W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee for the American Society of Clinical Oncology (ASCO).

Read more


Page 2 of 3012345678...Last »

Upcoming Events

MORE EVENTS »